SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001387131-20-008775
Filing Date
2020-10-05
Accepted
2020-10-05 17:30:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT admp-s3_100620.htm S-3 161832
3 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN, LAW CORPORATION ex5-1.htm EX-5.1 10672
4 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-2.htm EX-23.2 3446
5 filename5.htm COVER 5636
  Complete submission text file 0001387131-20-008775.txt   182745
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-249331 | Film No.: 201224635
SIC: 2834 Pharmaceutical Preparations